Related Experiment Video
Updated: Mar 8, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori Therapy in the West
David Y Graham1, Emiko Rimbara2
1Department of Medicine, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, USA.
Clarithromycin-based therapy for Helicobacter pylori is failing due to resistance. New 4-drug regimens show promise, but local data is crucial for effective treatment selection.
Area of Science:
- Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Antimicrobial resistance is a growing problem for H. pylori eradication.
- Clarithromycin triple therapy is no longer effective in most cases.
Purpose of the Study:
- To review factors influencing H. pylori eradication outcomes.
- To discuss effective 4-drug regimens and treatment failure strategies.
- To provide recommendations for empiric H. pylori treatment in Japan.
Main Methods:
- Literature review of H. pylori eradication therapies.
- Analysis of factors affecting treatment success.
- Evaluation of current 4-drug regimens.
- Discussion of treatment failure management.
Main Results:
- Clarithromycin resistance has rendered standard triple therapy largely ineffective.
- Four-drug regimens are effective but have limitations.
- Predicting treatment outcomes requires considering local resistance patterns.
Conclusions:
- Empiric H. pylori treatment should prioritize locally effective regimens.
- Local treatment success data is more valuable than external guidelines.
- Adapting treatment strategies based on local resistance is essential for H. pylori eradication.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

